ANTI-VGKC ANTIBODY POSITIVE

This adverse event was reported 3 times

These drugs are most commonly taken by patients reporting ANTI-VGKC ANTIBODY POSITIVE:

# Drug Count
0 ACETAMINOPHEN 1
1 ACETAMINOPHEN 500MG 1
2 ACETAMINOPHEN TABLET EXTENDED RELEASE 1
3 ADRENALINUM 1
4 BACLOFEN 1
5 CARBAMAZEPINE 1
6 COPPER 1
7 CUPRIC CHLORIDE 1
8 CYANOCOBALAMIN 1
9 DIAZEPAM 1
See all common drugs associated with ANTI-VGKC ANTIBODY POSITIVE

ANTI-VGKC ANTIBODY POSITIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CUPRIC CHLORIDE 1 0.0013
1 PHENYTOIN 1 0.0000
2 CYANOCOBALAMIN 1 0.0000
3 COPPER 1 0.0000
4 OCRELIZUMAB 1 0.0000
5 EPINEPHRINE 1 0.0000
6 CARBAMAZEPINE 1 0.0000
7 VALACYCLOVIR HYDROCHLORIDE 1 0.0000
8 LEVETIRACETAM ORAL 1 0.0000
9 LEVETIRACETAM INJECTION 1 0.0000
See all drugs enriched for association with ANTI-VGKC ANTIBODY POSITIVE

ANTI-VGKC ANTIBODY POSITIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 PCSK9 Inhibitor [EPC] 1 0.0000
1 Copper-containing Intrauterine Device [EPC] 1 0.0000
2 Catecholamine [EPC] 1 0.0000
3 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
4 Mood Stabilizer [EPC] 1 0.0000
5 Anti-epileptic Agent [EPC] 1 0.0000
6 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
7 Vitamin B12 [EPC] 1 0.0000
8 Benzodiazepine [EPC] 2 0.0000
9 Corticosteroid [EPC] 1 0.0000
See all drug classes enriched for association with ANTI-VGKC ANTIBODY POSITIVE